Buprenorphine And Naloxone Tablet
Product Images NDC 63629-9482

HCI stands for Human-Computer Interaction. This field is focused on the design, evaluation, and implementation of interactive computer systems for human use. HCI aims to create user-friendly and efficient digital interfaces by considering psychological, social, and cultural factors. It incorporates principles from computer science, design, psychology, and anthropology to improve user experience and productivity. Examples of HCI include website design, mobile apps, video games, and virtual reality systems.*

This is a pharmaceutical product description for Buprenorphine and Naloxone Sublingual Tablets, USP with a strength of 2 mg/0.5 mg. The tablets are to be stored at a temperature range of 20° to 25°C and should be kept out of reach of children. The product has potential harmful effects, causing children accidentally taking it to need emergency medical care. The description includes the content of the tablets, which contain 2.16mg buprenorphine hydrochloride, equivalent to 2 mg buprenorphine base, and 0.61 mg naloxone hydrochloride dihydrate, equivalent to 0.5 mg naloxone base, per sublingual tablet. The document lists a National Drug Code of 63629-9482-01 and provides prescribing information for pharmacists.*